DexCom Inc (DXCM)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	2,436,400	2,439,000	2,468,500	2,388,200	2,288,900	2,173,600	2,044,500	1,947,600	1,883,100	1,814,400	1,767,100	1,734,700	1,680,500	1,607,000	1,500,500	1,367,500	1,280,100	1,190,300	1,096,800	1,019,200
Revenue (ttm)	US$ in thousands	4,033,000	3,954,000	3,934,800	3,801,800	3,622,300	3,403,000	3,197,600	3,022,500	2,909,800	2,792,800	2,673,400	2,572,300	2,448,500	2,319,200	2,169,900	2,026,600	1,926,700	1,820,600	1,716,000	1,600,600
Gross profit margin		60.41%	61.68%	62.74%	62.82%	63.19%	63.87%	63.94%	64.44%	64.72%	64.97%	66.10%	67.44%	68.63%	69.29%	69.15%	67.48%	66.44%	65.38%	63.92%	63.68%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,436,400K ÷ $4,033,000K
= 60.41%

The gross profit margin of DexCom Inc has shown a relatively stable trend over the past few years, reflecting the company's ability to effectively manage its production costs and generate profits from its core activities.

From March 31, 2020, to June 30, 2021, we observe a consistent increase in the gross profit margin, indicating improved efficiency in cost control and revenue generation. The margin reached its peak at 69.29% on September 30, 2021, which demonstrates strong profitability during this period.

However, starting from December 31, 2021, we see a slight decline in the gross profit margin, dropping to 60.41% by December 31, 2024. This downward trend may suggest challenges in maintaining cost efficiencies or facing pricing pressures in the market.

Overall, DexCom Inc's gross profit margin performance indicates a historically sound ability to generate profits from its core operations, although recent data points to potential concerns that require further analysis and monitoring.